Sei-Ichiro Motegi Selected Research

Polymyositis

2/2022	Anti-polymyositis/Scl antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and antiphospholipid syndrome.
1/2021	Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sei-Ichiro Motegi Research Topics

Disease

17	Systemic Scleroderma (Systemic Sclerosis) 01/2024 - 11/2013
12	Dermatomyositis (Dermatopolymyositis) 04/2024 - 08/2016
11	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024 - 07/2014
9	Fibrosis (Cirrhosis) 10/2021 - 09/2014
7	Reperfusion Injury 07/2023 - 03/2015
7	Pressure Ulcer (Bedsore) 07/2023 - 01/2016
6	Dermatitis 04/2024 - 08/2020
6	Wounds and Injuries (Trauma) 11/2023 - 04/2015
6	Neoplasms (Cancer) 01/2021 - 07/2006
6	digital ulcers 03/2018 - 11/2014
5	Atopic Dermatitis (Atopic Eczema) 03/2024 - 01/2022
5	Melanoma (Melanoma, Malignant) 01/2021 - 06/2003
5	Suppuration 01/2020 - 01/2016
5	Sclerosis 01/2019 - 07/2014
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2021
3	Nephrogenic Fibrosing Dermopathy 01/2021 - 09/2014
3	Ischemia 01/2020 - 05/2018
3	Hypoxia (Hypoxemia) 01/2019 - 11/2015
2	Skin Diseases (Skin Disease) 10/2023 - 09/2023
2	Inflammation (Inflammations) 09/2023 - 10/2019
2	Disease Progression 05/2022 - 08/2021
2	Polymyositis 02/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2021
2	Pain (Aches) 02/2021 - 07/2017
2	Werner Syndrome (Werner's Syndrome) 02/2021 - 01/2016
2	Ulcer 02/2021 - 02/2021
2	Peripheral Arterial Disease 01/2021 - 11/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 02/2017
2	Pilomatrixoma 01/2020 - 04/2018
2	Dermatofibrosarcoma 12/2019 - 01/2019
2	Eosinophilia 01/2019 - 07/2013
2	Amyloidosis 05/2018 - 08/2017
2	Rheumatoid Arthritis 01/2018 - 02/2015
2	Acro-Osteolysis (Acroosteolysis) 02/2015 - 11/2014
2	Angioedema 02/2014 - 07/2013
1	Pulmonary Alveolar Proteinosis 04/2024
1	Respiratory Insufficiency (Respiratory Failure) 04/2024
1	Lung Diseases (Lung Disease) 04/2024
1	Peptic Esophagitis (Reflux Esophagitis) 01/2024

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 04/2024 - 06/2003
7	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2003
6	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021 - 10/2018
5	Botulinum Toxins (Botulinum Toxin)IBA 07/2021 - 07/2017
4	batrachotoxinin A 20-alpha-benzoateIBA 07/2021 - 07/2017
4	AutoantibodiesIBA 01/2021 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2014
3	Adenosine Triphosphate (ATP)IBA 12/2023 - 01/2019
3	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022 - 08/2016
3	indium-bleomycinIBA 10/2021 - 01/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 07/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2019
2	Periodic AcidIBA 04/2024 - 05/2017
2	Imiquimod (Aldara)FDA LinkGeneric 12/2023 - 01/2021
2	CollagenIBA 11/2023 - 01/2020
2	Therapeutic UsesIBA 09/2023 - 07/2021
2	kaempferolIBA 09/2023 - 10/2019
2	Bosentan (Tracleer)FDA Link 06/2023 - 01/2017
2	Dasatinib (BMS 354825)FDA Link 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 11/2015
2	Glycoproteins (Glycoprotein)IBA 02/2022 - 01/2019
2	baricitinibIBA 01/2022 - 01/2022
2	SteroidsIBA 01/2022 - 01/2016
2	Collagen Type I (Type I Collagen)IBA 10/2021 - 01/2019
2	Amino Acids FDA Link 01/2021 - 11/2014
2	HomocysteineIBA 01/2021 - 11/2014
2	Methionine (L-Methionine)FDA Link 01/2021 - 11/2014
2	CytokinesIBA 01/2021 - 06/2017
2	ZincIBA 08/2020 - 08/2019
2	ApelinIBA 01/2020 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 04/2018
2	LigandsIBA 01/2019 - 11/2008
2	Small Interfering RNA (siRNA)IBA 10/2018 - 11/2015
2	Type A Botulinum Toxins (Botox)FDA Link 05/2018 - 03/2015
2	Immunoglobulins (Immunoglobulin)IBA 05/2018 - 12/2014
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 05/2018 - 08/2017
2	Collagen Type IV (Type IV Collagen)IBA 05/2017 - 02/2017
2	Endothelin-1 (Endothelin 1)IBA 11/2015 - 09/2014
2	RNA Polymerase IIIIBA 02/2015 - 07/2014
2	anti-scl-70 autoantibodiesIBA 11/2014 - 07/2014
2	Chemokine CCL26IBA 01/2014 - 07/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024
1	Lipoproteins (Lipoprotein)IBA 04/2024
1	abrocitinibIBA 03/2024
1	Proton Pump InhibitorsIBA 01/2024
1	Messenger RNA (mRNA)IBA 11/2023
1	Immunoglobulin A (IgA)IBA 10/2023
1	calcipotriene (calcipotriol)FDA LinkGeneric 09/2023
1	involucrinIBA 09/2023
1	FlavonoidsIBA 09/2023
1	Thymic Stromal LymphopoietinIBA 09/2023
1	Filaggrin ProteinsIBA 09/2023
1	Immunologic Factors (Immunomodulators)IBA 09/2023
1	loricrinIBA 09/2023

Therapy/Procedure

9	Therapeutics 04/2024 - 11/2017
3	Injections 01/2021 - 07/2017
2	Subcutaneous Injections 12/2017 - 06/2017
1	Aftercare (After-Treatment) 04/2024